logo
episode-header-image
Dec 2021
32m 8s

Knowledge and Practice Patterns Among Pu...

AMERICAN COLLEGE OF CHEST PHYSICIANS
About this episode
CHEST December 2021, Volume 160, Issue 6 Gerard A. Silvestri, MD, FCCP, and Adam H. Fox, MD, join CHEST Podcast Moderator Dominique Pepper, MD, to discuss the current knowledge and practice of pulmonologists regarding biomarker testing and targeted therapies in advanced non-small cell lung cancer. DOI: https://doi.org/10.1016/j.chest.2020.08.1323 
Up next
Yesterday
Association of Recovery Rate From Exertional Desaturation With Disease Progression and Mortality Risk in Patients With Fibrotic Interstitial Lung Disease
Albina Tyker, MD, and Kerri A. Johannson, MD, MPH, join CHEST® Journal Podcast Moderator Alice Gallo De Moraes, MD, FCCP, to discuss their research into the association between recovery time from exertional desaturation following a 6-minute walk test with disease severity and pro ... Show More
30m 1s
Jun 1
June 2026 CHEST Journal Editor Highlights
CHEST June 2026, Volume 169, Issue 6 CHEST® journal's Editor in Chief Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST June 2026 issue, including an exploration of management and long-term outcomes of persistent tachypnea of infancy across Euro ... Show More
19m 27s
Jun 1
Efficacy of Antiinflammatory Therapies for Adults With Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and Network Meta-Analysis
Shota Yamamoto, MD, PhD; Takayuki Niitsu, MD; and Kenneth N. Olivier, MD, MPH, join CHEST® Journal Podcast Moderator Gretchen Winter, MD, to discuss their research into the current efficacy and safety profile of antiinflammatory therapies for bronchiectasis. DOI: 10.1016/j.chest. ... Show More
37m 32s
Recommended Episodes
Mar 2024
Episode 171: ASCO-GU Top Clinical Data With Pedro Barata
Dr. Pedro Barata, Director of the Clinical Genitourinary Medical Oncology Research Program at UH Seidman Cancer Center, provides an exclusive round-up of the most groundbreaking and practice-changing research unveiled at the ASCO GU 2024 meeting. With expertise and insight, he de ... Show More
46m 7s
Oct 2022
PET/CT in Resectable Non-Small Cell Lung Cancer
Dr. Lauren Kim summarizes major take home points from "Use of Preoperative FDG PET/CT and Survival of Patients with Resectable Non-Small Cell Lung Cancer" by Dr. Wan-Ming Chen and colleagues. Use of Preoperative FDG PET/CT and Survival of Patients with Resectable Non–Small Cell L ... Show More
8m 13s
Feb 2024
Lung Cancer Screening with Low Dose CT
Dr. Lauren Kim discusses results from the 20-year follow-up of the International Early Lung Cancer Action Program with Dr. Claudia Henschke, Dr. Rowena Yip, and Dr. David Yankelevitz. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Henschke an ... Show More
36m 43s
May 2024
S2 Episode 1: Tumor Trash or Treasure? Liquid Biopsy for Colorectal Cancer
Are you using liquid biopsies in your practice? Join Drs Benjamin Schlechter and Pashtoon Kasi as they review the latest clinical applications of ctDNA and liquid biopsies in colorectal cancer. Relevant disclosures can be found with the episode show notes on Medscape https://www. ... Show More
27m 24s
May 2024
Ep. 172 HPV and Oropharyngeal Cancer: Evolving Insights and Implications with Dr. Mihir Patel
In this episode, Dr. Mihir Patel, Professor of Otolaryngology at Emory University and expert in Transoral Robotic Surgery (TORS), discusses HPV-positive head and neck cancer with host Dr. Ashley Agan. --- CHECK OUT OUR SPONSOR Medtronic ENT https://www.medtronic.com/en-us/healthc ... Show More
1h 7m
Oct 2022
Oct 14, 2022 This Week in Cardiology Podcast
<p>Chest pain evaluation in the ED, peer review, the NordICC trial, and a surgeon lost too early are the topics John Mandrola, MD, discusses in this week's podcast. <em>This podcast is intended for healthcare professionals only</em>. <u>To read a partial transcript or to comment, ... Show More
21m 21s
Jul 2021
Episode 39: R-CHOP versus DA-EPOCH-R for Double-Hit Lymphoma
Alan Skarbnik (@ASkarbnik), MD, director of the lymphoma and CLL program, Novant Health (Charlotte, NC), and Aaron Goodman (@AaronGoodman33), MD, hematologist, University of California San Diego, join the show for a long-awaited debate: treating double-hit lymphoma with R-CHOP vs ... Show More
1h 6m